Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause

Maturitas

Volumn 40, Issue 1, 2001, Pages 85-94

  Pelissier C ^a   Maroni, M ^b   Yaneva, H ^a   Brin, S ^b   Peltier Pujol, F ^b   Jondet, M ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SANOFI   (France)

^c Cabinet d'Anatomie Et De Cytologie Pathologiques   (France)

Author keywords

Bleeding pattern; Chlormadinone acetate; Endometrial biopsy; Hormone replacement therapy; Lipid profile; Postmenopausal women; Progesterone

Indexed keywords

CHLORMADINONE ACETATE; ESTRADIOL; PROGESTERONE;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CLIMACTERIUM; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYSTERECTOMY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MENOPAUSE; METRORRHAGIA; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SPOTTING; TREATMENT OUTCOME; VERTIGO;

BIOPSY; CHLORMADINONE ACETATE; CHOLESTEROL; DIZZINESS; DRUG THERAPY, COMBINATION; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PROGESTERONE; PROGESTERONE CONGENERS; SLEEP STAGES; TRIGLYCERIDES; UTERINE HEMORRHAGE;

EID: 0035980312     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00170-0     Document Type: Article

References (34)

1. Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: Placebo-controlled trial of its gynecologic and metabolic actions
2. Estrogen in prevention and treatment of osteoporosis
3. Hormonal replacement therapy and the skeletal system
4. Hormone therapy to prevent disease and prolong life in post-menopausal women
5. Post-menopausal hormone therapy and mortality
6. Mortality in a cohort of long-term users of hormone replacement therapy. A reupdated analysis
7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women. The Post-menopausal Estrogen/Progestin Interventions (PEPI) trial
8. Five years with continuous combined estrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins and bleeding pattern
9. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: Influence of bleeding pattern and secretory changes
10. Contraception progestative par l'acétate de chlormadinone chez des femmes à risque vasculaire
11. Administration prolongée d'acétate de chlormadinone. Effets métaboliques, tensionnels et hormonaux
12. Quality of life after the menopause: Influence of hormonal replacement therapy
13. Dating the endometrial biopsy
14. Endometrial morphology in a symptomatic postmenopausal women
15. Induction of amenorrhea during hormone replacement therapy: Optimal micronized progesterone dose. A multicenter study
16. Effects of hormone replacement therapy on the endometrium and lipid parameters: A review of randomized clinical trials, 1985 to 1995
17. A new oral estrogen/progestin combination for postmenopausal hormonal substitution. An open multicentric field study
18. Six months endometrium histology data on continuous estradiol combined with different cyclic dosages of dydrogesterone in over 300 post-menopausal women
19. Histological comparison of chlormadinone acetate (CA) and micronized progesterone (MP) in menopausal sequential hormonal therapy (HRT)
20. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: A multicenter study
21. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone
22. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17β oestradiol
23. Changes in the withdrawal bleeding pattern and endometrial histology during 17β-estradiol - Dydrogesterone therapy in post-menopausal women: A 2-year prospective study
24. Effects of hormone replacement therapy on endometrial histology in post-menopausal women. The post-menopausal estrogen/progestin interventions (PEPI) trial
25. Incidence of endometrial hyperplasia in post-menopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
26. A simple method for determining the optimal dosage of progestin in post-menopausal women receiving estrogens
27. Action anti-ovulatoire de l'acétate de chlormadinone
28. Megestrol acetate for the prevention of hot flashes
29. Hot flashes. Physiology, hormonal therapy and alternative therapies
30. Alternatives to estrogen for menopausal symptoms
31. Bleeding patterns in post-menopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate
32. Les progestatifs de synthèse
33. Hormone replacement therapy: Clinical benefits and side effects